These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29110755)

  • 41. You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.
    Umeukeje EM; Young BA; Fullerton SM; Cavanaugh K; Owens D; Wilson JG; Burke W; Blacksher E
    J Am Soc Nephrol; 2019 Apr; 30(4):526-530. PubMed ID: 30858224
    [No Abstract]   [Full Text] [Related]  

  • 42. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV; Sheridan AM
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
    Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
    Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
    Young BA; Blacksher E; Cavanaugh KL; Freedman BI; Fullerton SM; Kopp JB; Umeukeje EM; West KM; Wilson JG; Burke W;
    Am J Nephrol; 2019; 50(4):303-311. PubMed ID: 31480040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. APOL1 and nephropathy progression in populations of African ancestry.
    Freedman BI
    Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic ancestry, proportion of African ancestry, and apolipoprotein L1 risk variants in kidney recipients.
    Zhang Z; Sun Z; Heeger P; Menon MC
    Am J Transplant; 2024 Sep; 24(9):1710-1712. PubMed ID: 38734416
    [No Abstract]   [Full Text] [Related]  

  • 47. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case Report: Renal Failure due to Focal Segmental Glomerulosclerosis in a Patient with Murine Typhus.
    Blanton LS; Berman MA; Afrouzian M
    Am J Trop Med Hyg; 2020 Sep; 103(3):1017-1019. PubMed ID: 32588799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
    Freedman BI; Skorecki K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):2006-13. PubMed ID: 24903390
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
    Waziri B; Raji YE; Ekrikpo UE; Naicker S
    J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
    Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
    Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.
    Kruzel-Davila E; Wasser WG; Skorecki K
    Semin Nephrol; 2017 Nov; 37(6):490-507. PubMed ID: 29110756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The
    Freedman BI; Moxey-Mims M
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):940-942. PubMed ID: 29703792
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasma apolipoprotein L1 levels do not correlate with CKD.
    Bruggeman LA; O'Toole JF; Ross MD; Madhavan SM; Smurzynski M; Wu K; Bosch RJ; Gupta S; Pollak MR; Sedor JR; Kalayjian RC
    J Am Soc Nephrol; 2014 Mar; 25(3):634-44. PubMed ID: 24231663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
    Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
    Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
    Bruggeman LA; O'Toole JF; Sedor JR
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F1-F8. PubMed ID: 30332315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.